Gregory Norden, Director at Royalty Pharma plc (RPRX), sold 3,045 shares at $53.00 ($161K) on 2026-05-14, disclosed to the SEC on 2026-05-15.
Scheduled sale ($161k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZTS | SELL | 2021-11-09 | $972K | — | Filing → |
| NSTG | SELL | 2020-12-09 | $1.2M | — | Filing → |
| NSTG | SELL | 2020-08-13 | $388K | — | Filing → |